JPWO2021090911A1 - - Google Patents
Info
- Publication number
- JPWO2021090911A1 JPWO2021090911A1 JP2021555123A JP2021555123A JPWO2021090911A1 JP WO2021090911 A1 JPWO2021090911 A1 JP WO2021090911A1 JP 2021555123 A JP2021555123 A JP 2021555123A JP 2021555123 A JP2021555123 A JP 2021555123A JP WO2021090911 A1 JPWO2021090911 A1 JP WO2021090911A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019203524 | 2019-11-08 | ||
JP2019230543 | 2019-12-20 | ||
PCT/JP2020/041522 WO2021090911A1 (ja) | 2019-11-08 | 2020-11-06 | タンパク質凝集塊を含有する細胞を選択的に死滅させる方法、そのキット、タンパク質ミスフォールディング病治療薬及び血液製剤からのタンパク質凝集塊除去製剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPWO2021090911A1 true JPWO2021090911A1 (ja) | 2021-05-14 |
Family
ID=75849164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021555123A Pending JPWO2021090911A1 (ja) | 2019-11-08 | 2020-11-06 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20220249394A1 (ja) |
EP (1) | EP4056175A4 (ja) |
JP (1) | JPWO2021090911A1 (ja) |
CN (1) | CN114615973A (ja) |
WO (1) | WO2021090911A1 (ja) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6150172A (en) * | 1999-01-08 | 2000-11-21 | The United States Of America As Represented By The Secretary Of Agriculture | Method and kit for extracting prion protein |
AU2004251511A1 (en) * | 2003-06-23 | 2005-01-06 | Neurochem (International) Limited | Treatment of protein aggregation disorders |
JP2009013126A (ja) | 2007-07-06 | 2009-01-22 | Gifu Univ | プリオンタンパク質構造変換抑制剤 |
JP2009029752A (ja) | 2007-07-27 | 2009-02-12 | Univ Of Tsukuba | 異常型プリオンタンパク質の形成抑制剤 |
JP2009167128A (ja) | 2008-01-16 | 2009-07-30 | Asahi Kasei Medical Co Ltd | プリオン除去機能を有するフィルター |
JP5368780B2 (ja) | 2008-12-05 | 2013-12-18 | コマツNtc株式会社 | 工作機械 |
WO2017148945A1 (en) * | 2016-02-29 | 2017-09-08 | Universität Zürich | Hexafluoro-2-propanol as inhibitor of tumor cell invasion |
JP2018035099A (ja) | 2016-08-31 | 2018-03-08 | 国立大学法人 長崎大学 | プリオン病予防・治療剤 |
JP7178607B2 (ja) * | 2018-02-23 | 2022-11-28 | 学校法人麻布獣医学園 | アミロイドタンパク質を抽出する試薬 |
-
2020
- 2020-11-06 JP JP2021555123A patent/JPWO2021090911A1/ja active Pending
- 2020-11-06 EP EP20885454.7A patent/EP4056175A4/en active Pending
- 2020-11-06 CN CN202080076336.XA patent/CN114615973A/zh active Pending
- 2020-11-06 WO PCT/JP2020/041522 patent/WO2021090911A1/ja unknown
-
2022
- 2022-04-28 US US17/731,942 patent/US20220249394A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2021090911A1 (ja) | 2021-05-14 |
US20220249394A1 (en) | 2022-08-11 |
EP4056175A4 (en) | 2023-12-06 |
CN114615973A (zh) | 2022-06-10 |
EP4056175A1 (en) | 2022-09-14 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20231102 |